The DAPA‐DIET study: Metabolic response to Dapagliflozin combined with dietary carbohydrate restriction in patients with Type 2 Diabetes Mellitus and Obesity—A longitudinal cohort study

The DAPA‐DIET study: Metabolic response to Dapagliflozin combined with dietary carbohydrate restriction in patients with Type 2 Diabetes Mellitus and Obesity—A longitudinal cohort study

Abstract Objective The cardio‐renal benefits of sodium glucose‐like transporter 2 inhibitor (SGLT2i) therapies have been demonstrated in patients with and without type 2 diabetes. However, no studies have explored the long‐term metabolic effects of SGLT2i, combined with dietary carbohydrate restrict...

Full description

Bibliographic Details
Main Authors: Petra Hanson, Harpal Randeva, Dan J. Cuthbertson, Paul J. O'Hare, Nick Parsons, Kamaljit Chatha, Gemma Reidy, Martin O. Weickert, Thomas M. Barber
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
appetite
carbohydrate restriction
energy expenditure
fat mass
lean mass
metabolism
Online Access:https://doi.org/10.1002/edm2.381

Internet

https://doi.org/10.1002/edm2.381

Similar Items